1HY7 image
Entry Detail
PDB ID:
1HY7
Keywords:
Title:
A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2001-01-18
Release Date:
2002-01-18
Method Details:
Experimental Method:
Resolution:
1.50 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:STROMELYSIN-1
Chain IDs:A, B
Chain Length:173
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.
J.Med.Chem. 44 1060 1071 (2001)
PMID: 11297453 DOI: 10.1021/jm000477l

Abstact

A series of carboxylic acids were prepared from a propargylglycine scaffold and tested for efficacy as matrix metalloproteinase (MMP) inhibitors. Detailed SAR for the series is reported for four enzymes within the MMP family. The inhibitors were typically potent against collagenase-3 (MMP-13) and gelatinase A (MMP-2), while they spared collagenase-1 (MMP-1) and only moderately inhibited stromelysin (MMP-3). Compound 40 represents a typical inhibition profile of a compound with reasonable potency. Introduction of polar groups was required in order to generate inhibitors with acceptable water solubility, and this often resulted in a loss of potency as in compound 63. High serum protein binding proved to be a difficult hurdle with many compounds such as 48 showing >99% binding. Some compounds such as 64 displayed approximately 90% binding, but no reliable method was discovered for designing molecules with low protein binding. Finally, selected data regarding the pharmacokinetic behavior of these compounds is presented.

Legend

Protein

Chemical

Disease

Primary Citation of related structures